Latest News about VRTX
Recent news which mentions VRTX
From InvestorPlace
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 13, 2023
From Benzinga
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
December 13, 2023
From Benzinga
Vertex's Non-Opioid Diabetes Associated Nerve Pain Treatment Candidate Aces Mid-Stage Trial
December 13, 2023
Tickers
VRTX
From Benzinga
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
December 13, 2023
From InvestorPlace
From MarketWatch
1 Biotech Stock That Could Be the Next Amgen
December 13, 2023
From Motley Fool
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
December 13, 2023
From Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
From InvestorPlace
Why CRISPR Stock Keeps Falling
December 11, 2023
From Motley Fool
From Motley Fool
3 Unstoppable Stocks to Buy Right Now
December 10, 2023
From Motley Fool
From Motley Fool
Forget the "Magnificent Seven": Buy This Stock Instead
December 09, 2023
Tickers
VRTX
From Motley Fool
From Motley Fool
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 08, 2023
From Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
From MarketWatch
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
December 08, 2023
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
December 07, 2023
From Motley Fool
5 Unstoppable Trends to Invest $1,000 in for 2024
December 07, 2023
From Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
December 05, 2023
Tickers
VRTX
From Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Invitae
December 05, 2023
From Motley Fool
Looking Into Vertex Pharmaceuticals's Recent Short Interest
December 04, 2023
Tickers
VRTX
From Benzinga
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
From Motley Fool
Where Will Vertex Pharmaceuticals Be in 10 Years?
December 04, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.